Global Phase III Ovarian Cancer Study Turnaround Case Study

This case study details how Worldwide Clinical Trials successfully rescued a failing Phase III ovarian cancer study for a biotech client. Faced with challenges from a previous CRO, Worldwide expedited timelines, stabilized operations, and ensured timely delivery. Key outcomes included improved data integrity and successful patient enrollment across 136 sites in 12 countries. Learn how Worldwide's customized approach and expertise in oncology led to a successful regulatory submission.